CIMG · CIMG Inc. · Insider Trading

Yumei Liu beneficially owns such shares of common stock through his indirect 100% ownership of Joyer investment Limited. Yumei Liu is the sole director of Joyer investment Limited

Zheng Dai is the sole director of Dada Business Trading Co., Ltd. Dada Business Trading Co., Limited is governed by its sole director, Mr. Zheng Dai. As such, Mr. Dai has voting and investment discretion with respect to the ordinary shares held of record by Dada Business Trading Co., Limited and may be deemed to have beneficial ownership of the shares held directly by Dada Business Trading Co., Limited. Yubo Yang is the sole shareholder of Dada Business Trading Co., Ltd.

Xiaodong Liu beneficially owns such shares of common stock through his indirect 100% ownership of VMADE CO. LIMITED. Xiaodong Liu is the sole director of VMADE CO. LIMITED.

Yujie Liu beneficially owns such shares of common stock through his indirect 100% ownership of YY Tech Inc. Yujie Liu is the sole director of YY Tech Inc.

On October 18, 2024, Future Science and Technology Co. Ltd exercised its cashless option to purchase 20,990 shares of common stock pursuant to warrants issued by the Issuer sold under the convertible note and warrant purchase agreement dated April 27, 2024.

Yumei Liu beneficially owns 20,990 shares of common stock through her indirect 100% ownership of Future science and Technology Co. Ltd pursuant to the cashless exercise of warrants issued by the Issuer under the convertible note and warrant purchase agreement dated April 27, 2024. Additionally, Yumei Liu beneficially owns 542,517 shares of common stock through her direct 100% ownership of JOYER INVESTMENT LIMITED.

Yumei Liu beneficially owns 20,990 shares of common stock through her indirect 100% ownership of Future science and Technology Co. Ltd pursuant to the cashless exercise of warrants issued by the Issuer under the convertible note and warrant purchase agreement dated April 27, 2024. Additionally, Yumei Liu beneficially owns 542,517 shares of common stock through her direct 100% ownership of JOYER INVESTMENT LIMITED.

Shelei Jiang beneficially owns such shares of common stock through his indirect 100% ownership of DYT INFO PTE. LTD. Shelei Jiang is the sole director of DYT INFO PTE. LTD.

Yumei Liu beneficially owns such shares of common stock through her indirect 100% ownership of Future science and Technology Co. Ltd and JOYER INVESTMENT LIMITED.

Shelei Jiang beneficially owns such shares of common stock through his indirect 100% ownership of DYT INFO PTE. LTD.

Yumei Liu beneficially owns such shares of common stock through her indirect 100% ownership of Future science and Technology Co. Ltd and JOYER INVESTMENT LIMITED.

Pursuant to the convertible promissory note (the "Note") dated April 30, 2024, the issuer shall pay the reporting person, an amount in cash representing all outstanding principal, accrued and unpaid interest, and any other amounts outstanding pursuant to the terms of the Note on April 30, 2025 ("Maturity Date"). The Note will be convertible into the issuer's common stock until it is fully paid.

Yumei Liu beneficially owns such shares of common stock through her indirect 100% ownership of Future science and Technology Co. Ltd.

Pursuant to the convertible promissory note (the "Note") dated April 30, 2024, the issuer shall pay the reporting person, an amount in cash representing all outstanding principal, accrued and unpaid interest, and any other amounts outstanding pursuant to the terms of the Note on April 30, 2025 ("Maturity Date"). The Note will be convertible into the issuer's common stock until it is fully paid.

Yumei Liu beneficially owns such shares of common stock through her indirect 100% ownership of Future science and Technology Co. Ltd.

Reflects the sale of shares of common stock by the reporting person pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person.

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $5.15 to $5.30, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.

On December 28, 2022 the Issuer effected a 1-for 35 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Reflects the sale of shares of common stock by the reporting person pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person.

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $7.05 to $7.59, inclusive. For all transactions reported in this Form 4/A utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.

On December 28, 2022 the Issuer effected a 1-for 35 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4/A have been adjusted to reflect the Reverse Stock Split.

On September 15, 2023, the reporting person filed a Form 4 which inadvertently reported 133,558 as the Amount of Securities Beneficially Owned Following Reported Transaction. The correct Amount of Securities Beneficially Owned Following Reported Transaction is 133,559 shares of Common Stock.

Reflects the sale of shares of common stock by the reporting person pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person.

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $7.25 to $7.70, inclusive. For all transactions reported in this Form 4/A utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.

On December 28, 2022 the Issuer effected a 1-for 35 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4/A have been adjusted to reflect the Reverse Stock Split.

On September 15, 2023, the reporting person filed a Form 4 which inadvertently reported 134,358 as the Amount of Securities Beneficially Owned Following Reported Transaction. The correct Amount of Securities Beneficially Owned Following Reported Transaction is 134,359 shares of Common Stock.

The options have an exercise price of equal to the fair market value at the time of grant.

The options vest as follows: (i) 2,000 options shall vest on August 16, 2024; (ii) 2,000 options shall vest on August 16, 2025; and (iii) 2,000 options shall vest on August 16, 2026.

The restricted shares vest as follows: (i) 2,000 restricted shares shall vest on August 16, 2024; (ii) 2,000 restricted shares shall vest on August 16, 2025; and (iii) 2,000 restricted shares shall vest on August 16, 2026.

100% of the restricted shares of the Issuer's common stock shall vest on the one year anniversary of the grant date, subject to the Reporting Person's continued service as a director of the Issuer.

100% of the restricted shares of the Issuer's common stock shall vest on the one year anniversary of the grant date, subject to the Reporting Person's continued service as a director of the Issuer.

100% of the restricted shares of the Issuer's common stock shall vest on the one year anniversary of the grant date, subject to the Reporting Person's continued service as a director of the Issuer.

100% of the restricted shares of the Issuer's common stock shall vest on the one year anniversary of the grant date, subject to the Reporting Person's continued service as a director of the Issuer.

100% of the restricted shares of the Issuer's common stock shall vest on the one year anniversary of the grant date, subject to the Reporting Person's continued service as a director of the Issuer.

100% of the restricted shares of the Issuer's common stock shall vest on the one year anniversary of the grant date, subject to the Reporting Person's continued service as a director of the Issuer.

100% of the restricted shares of the Issuer's common stock shall vest on the one year anniversary of the grant date, subject to the Reporting Person's continued service as a director of the Issuer.

100% of the restricted shares of the Issuer's common stock shall vest on the one year anniversary of the grant date, subject to the Reporting Person's continued service as a director of the Issuer.

100% of the restricted shares of the Issuer's common stock shall vest on the one year anniversary of the grant date, subject to the Reporting Person's continued service as a director of the Issuer.

100% of the restricted shares of the Issuer's common stock shall vest on the one year anniversary of the grant date, subject to the Reporting Person's continued service as a director of the Issuer.

The options vest as follows: (i) 80,000 options shall vest on July 2, 2022; (ii) 60,000 options shall vest on July 2, 2023; and (iii) 60,000 options shall vest on July 2, 2024.

The options vest in installments of 10,000 on each of May 10, 2022, May 10, 2023 and May 10, 2024.

The options vest in installments of 10,000 on each of May 3, 2022, May 3, 2023 and May 3, 2024.

50% of the options (114,162) vested on April 22, 2021. The remainder of the options vest in installments of 57,081 on April 22, 2022 and 57,080 on April 22, 2023.

50% of the options (114,162) vested on March 18, 2021. The remainder of the options vest in installments of 57,081 on March 18, 2022 and 57,080 on March 18, 2023.

50% of the options (114,162) vested on March 18, 2021. The remainder of the options vest in installments of 57,081 on March 18, 2022 and 57,080 on March 18, 2023.

Represents 152,215 restricted shares of the Issuer's common stock which vest, subject to the reporting person's continued employment, as follows: (i) 50,739 restricted shares vested immediately; (ii) 50,739 restricted shares will vest on March 31, 2021; and (iii) 50,737 restricted shares vest on March 31, 2022.

Shares were forfeited solely to cover tax withholding obligations arising automatically upon partial vesting of restricted shares and issuance of the vested restricted shares.

50% of the options (114,162) vested on November 4, 2020. The remainder of the options vest in installments of 57,081 on November 4, 2021 and 57,080 on November 4, 2022.

50% of the options (114,162) vested on November 4, 2020. The remainder of the options vest in installments of 57,081 on November 4, 2021 and 57,080 on November 4, 2022.

50% of the options (114,162) vested on November 4, 2020. The remainder of the options vest in installments of 57,081 on November 4, 2021 and 57,080 on November 4, 2022.

On April 1, 2019, the reporting person was granted options to purchase 200,000 shares of the Issuer's common stock, as adjusted for the Issuer's l-for-3 reverse stock split, which became effective on November 12, 2019. The options vest, subject to the reporting person's continued employment, based on the Issuer's satisfaction of certain performance criteria. 133,333 options were to vest upon the Issuer's listing on any tier of the Nasdaq Stock Market on or before December 31, 2020. The Issuer's common stock began trading on the Nasdaq Capital Market on June 19, 2020, resulting in vesting of the options as to 133,333 shares.